Susan T. Hall - Concepedia

Author

Susan T. Hall

Research Triangle Park Foundation

Also Known As

Hans Peter Arnold, S T Hall, S. Hall, S. T. Hall, Susan Hall, Susan T. Hall

Publications

838

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Bausch Health (United States)Hospital Ruber Internacional

About

Susan T. Hall is an author at Research Triangle Park Foundation specializing in medicine, pharmacology, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	123
2	Pharmacology	3	3	85
3	Neurology	2	2	65
4	Health Sciences	1	1	17
5	Antimicrobial Pharmacokinetics	1	1	41

Susan T. Hall

Publications

738

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of adjunctive ezogabine (retigabine) in refractory partial epilepsy Martin J. Brodie, Holger Lerche, António Gil‐Nagel, Neurology	2010	189
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy Jacqueline A. French, Bassel Abou‐Khalil, Robert Leroy, Neurology	2011	181
The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection Remko van Leeuwen, Joep M. A. Lange, Elizabeth K. Hussey, AIDS	1992	123
Pharmacokinetics, Absolute Bioavailability, and Absorption Characteristics of Lamivudine Geoffrey J. Yuen, David M. Morris, Patricia K. Mydlow, The Journal of Clinical Pharmacology	1995	86
Pharmacokinetics of 3TC (GR109714X) Administered With and Without Food to HIV-infected Patients Jonathan B. Angel, E. K. Hussey, Susan T. Hall, Clinical Drug Investigation NeurovirologyMedicineAntimicrobial PharmacokineticsHivPharmacology	1993	41
Retigabine as adjunctive therapy in adults with partial-onset seizures: Integrated analysis of three pivotal controlled trials Roger J. Porter, David E. Burdette, António Gil‐Nagel, Epilepsy Research MedicineAdjunctive TherapyNeurologyPartial-onset Seizures	2012	38
Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies António Gil‐Nagel, Martin J. Brodie, Robert Leroy, Epilepsy Research Refractory Partial-onset SeizuresMedicineNeuropharmacologyInterim ResultsPharmacotherapy	2012	27
Interspecies Scaling and Pharmacokinetic Parameters of 3TC in Humans Elizabeth K. Hussey, Mick J. Daniel, Susan T. Hall, The Journal of Clinical Pharmacology	1994	19
Inhibition of antipyrine metabolite formation in rats<i>in vivo</i> J. C. Rhodes, Susan T. Hall, J. Brian Houston Xenobiotica	1984	17
Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making William L. Trepicchio, David M. Essayan, Susan T. Hall, The Pharmacogenomics Journal PharmacologyClinical TrialsMeeting ReportTherapeutic Decision MakingPharmacogenomics	2006	17

Page 1